Marex Group Securities Class Action: Lead Plaintiff Deadline December 8, 2025
Written by Emily J. Thompson, Senior Investment Analyst
Source: Globenewswire
Updated: 52 minutes ago0mins
- Lawsuit Notification: Rosen Law Firm reminds investors who purchased Marex Group securities between May 16, 2024, and August 5, 2025, to apply as lead plaintiffs by December 8, 2025, to participate in the class action and seek compensation.
- Fee Arrangement: Investors joining the lawsuit will incur no upfront costs, as the law firm operates on a contingency fee basis, thereby reducing the financial burden on investors.
- Case Background: The lawsuit alleges that Marex made materially false and misleading statements in its financial reports, resulting in investor losses once the true information was disclosed, which negatively impacted the company's reputation and market trust.
- Law Firm Advantage: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its successful track record and expertise in handling such cases.
MRX.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
No Data
Powered By
Intellectia
Analyst Views on MRX
Wall Street analysts forecast MRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRX is 50.60 USD with a low forecast of 43.00 USD and a high forecast of 58.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 37.540
Low
43.00
Averages
50.60
High
58.00
Current: 37.540
Low
43.00
Averages
50.60
High
58.00
Keefe Bruyette
Kyle Voigt
Outperform
maintain
$49 -> $50
2025-11-07
Reason
Keefe Bruyette
Kyle Voigt
Price Target
$49 -> $50
2025-11-07
maintain
Outperform
Reason
Keefe Bruyette analyst Kyle Voigt raised the firm's price target on Marex Group to $50 from $49 and keeps an Outperform rating on the shares.
Barclays
NULL -> Overweight
maintain
$40 -> $43
2025-11-07
Reason
Barclays
Price Target
$40 -> $43
2025-11-07
maintain
NULL -> Overweight
Reason
Barclays raised the firm's price target on Marex Group to $43 from $40 and keeps an Overweight rating on the shares. The company reported a solid Q3, the analyst tells investors in a research note.
Barclays
Overweight
downgrade
$52 -> $50
2025-08-14
Reason
Barclays
Price Target
$52 -> $50
2025-08-14
downgrade
Overweight
Reason
Barclays lowered the firm's price target on Marex Group to $50 from $52 and keeps an Overweight rating on the shares following the Q2 report. The company reported an earnings beat and its sales momentum continued into July, the analyst tells investors in a research note. The firm believes Marex also provided a strong rebuttal to a recent short report, answering many key questions.
Barclays
Benjamin Budish
Overweight
downgrade
$57 -> $52
2025-06-09
Reason
Barclays
Benjamin Budish
Price Target
$57 -> $52
2025-06-09
downgrade
Overweight
Reason
Barclays analyst Benjamin Budish lowered the firm's price target on Marex Group to $52 from $57 and keeps an Overweight rating on the shares.
See All Ratings
About MRX
Marex Group plc offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. Its segments include Clearing, Agency and Execution, Market Making, Hedging and Investment Solutions, and Corporate. The Clearing segment acts as the interface between exchanges and clients. This segment provides the connectivity that allows its clients access to exchanges and central clearing houses. The Agency and Execution segment matches buyers and sellers on an agency basis by facilitating price discovery primarily across energy and financial securities markets. Market Making segment acts as principal to provide direct market pricing to professional and wholesale counterparties, primarily metals, agriculture, energy, and financial securities markets. The Company also owns an equity market maker Winterflood Securities.
About the author
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sigh Up to Get Intellectia Insights
What is the strategic significance of Marex acquiring Winterflood Securities?
Why are investors encouraged to apply for lead plaintiff status by December 8, 2025?
How might Marex's stock price change after the class action lawsuit progresses?
What impact could the sale of Winterflood's custody business have on Marex's profitability?